Subscribe
shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
3 November 2020AmericasRory O'Neill

US agencies to work together against COVID-19 fakes

US federal agencies are to step up their cooperation on stemming the flow of counterfeit drugs, medical devices, and dietary supplements into the country through the international mail system.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.


Editor's picks

Smart ringleader: Could Ōura’s market dominance be under threat?
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

Editor's picks

Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025

More on this story

Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

More on this story

Americas
ICE targets COVID-19 vaccine fraud after seizing proceeds worth $26m
2 December 2020   The US Immigration and Customs Enforcement has unveiled the next stage of its operation to combat a wave of fraudulent vaccines and treatments, after seizing more than $26 million in illicit proceeds from COVID-19 related products over the past six months.
Americas
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
8 October 2020   US Customs and Border Protection officers have seized hundreds of thousands of counterfeit facemasks and unapproved COVID-19 related products worth more than $2.5m during the six weeks leading up to October 1.
Americas
US customs raids find thousands of fake COVID-19 test kits
5 May 2020   US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

More features

Trump’s march-in rights threat: Why pharma is rethinking collaborations
UK gets new IP minister following cabinet reshuffle
Barnes & Thornburg reveals five new IP leaders
Former PTAB judge joins Sterne Kessler
GSK escalates mRNA COVID-19 vaccine dispute
Smart ringleader: Could Ōura’s market dominance be under threat?
The flaw that landed Sanofi a win in the rare disease space
Roche resolves cancer test dispute with Stanford affiliated startup